Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FluMist Storage Concerns Discourage Coverage Recommendation From ACIP

Executive Summary

The American Academy of Pediatrics plans not to recommend use of MedImmune/Wyeth's FluMist intranasal flu vaccine over injectable vaccine due to storage concerns, AAP Committee of Infectious Diseases Chair Jon Abramson, MD, Wake Forest University, said
Advertisement

Related Content

Aventis Pegs Injectable Flu Vaccine As Key Sales Growth Driver
Aventis Pegs Injectable Flu Vaccine As Key Sales Growth Driver
FluMist 60,000-Patient Phase IV Safety Study To Be Conducted With Kaiser
FluMist 60,000-Patient Phase IV Safety Study To Be Conducted With Kaiser
Advertisement
UsernamePublicRestriction

Register

PS042045

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel